InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
46%
T+90 mean return
+3.3%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Romano Kelly A, Director. Officer active across 3 companies, notably Dorman Products, Inc.. In total, 22 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €282k. History available since 13 May 2021. The latest transaction was filed on 16 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations22 total
46 shares@ US$132.0323.6% of flowCommon StockSEC:0001628280-25-026762:0
5,695 shares0UGI Common StockSEC:0001415889-25-002992:0
15,000 shares@ US$2.258111.2% of flowCommon StockSEC:0001415889-24-018177:0
Ideal exit: 18 Mar 2025 (T+270)
27,400 shares@ US$2.415321.9% of flowCommon StockSEC:0001415889-24-018177:1
Ideal exit: 21 Mar 2025 (T+270)
1,471 shares0Common StockSEC:0001628280-24-026499:0
47 shares@ US$91.3317.2% of flowCommon StockSEC:0001628280-24-024467:0
4,470 shares0UGI Common StockSEC:0000884614-24-000026:0
1,510 shares0Common StockSEC:0001209191-23-033611:0
38 shares@ US$86.5413.3% of flowCommon StockSEC:0001209191-23-031348:0
2,600 shares0UGI Common StockSEC:0000884614-23-000015:0
30,000 shares@ US$3.2933.3% of flowCommon StockSEC:0001209191-22-060128:0
Ideal exit: 29 Aug 2023 (T+270)
1,223 shares0Common StockSEC:0001209191-22-033437:0
33 shares@ US$98.060.0001% mcap28.7% of flowCommon StockSEC:0001209191-22-032399:0
8,000 shares@ US$13.11100.0% of flowCommon StockSEC:0001209191-22-022001:0
Ideal exit: 26 Dec 2022 (T+270)
2,300 shares0UGI Common StockSEC:0001209191-22-007219:0
2,300 shares0UGI Common StockSEC:0001209191-22-007219
6,050 shares0UGI Common StockSEC:0001209191-22-005962:0
6,050 shares0UGI Common StockSEC:0001209191-22-005962
1,064 shares0Common StockSEC:0001209191-21-037508:0
1,064 shares0Common StockSEC:0001209191-21-037508
44 shares@ US$103.030.0001% mcap35.6% of flowCommon StockSEC:0001209191-21-033031:0
44 shares@ US$103.0335.6% of flowCommon StockSEC:0001209191-21-033031
22 of 22 declarations
About Romano Kelly A
Kelly A. Romano is a Board Member of Dorman Products, Inc., UGI CORP /PA/, and Athira Pharma, Inc. She contributes to the governance of these companies by bringing her expertise in strategy and business development.
